Negative Results for Chemoimmunotherapy Pancreatic Cancer TeloVac Trial

Telomerase peptide vaccine fails to improve advanced pancreatic cancer survival in patients given gemcitabine plus capecitabine...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.